Tim Farries | Independent Consultant Cell & Gene Therapies
Independent

Tim Farries, Independent Consultant Cell & Gene Therapies, Independent

Tim Farries is a freelance consultant as a specialist expert and leader in CMC regulatory and development aspects of cell and gene therapies, notably including viral vectors, genome editing, stem cell, RNA-based and CAR-T products. This experience comes from over 10 years in consulting, including as Chief Scientific Officer at ERA Consulting where he led teams that supported ground-breaking regulatory approvals for products using stem cells and genome editing. This expertise was founded on a career of more than 20 years in commercial development of cutting-edge therapeutics encompassing roles at small (Ark Therapeutics), medium (Sangamo Biosciences) and large (Novartis) developers. Prior to this he had obtained his degree in Biochemistry from the University of Oxford, and a Ph.D. from the Universities of Cambridge, and followed these with productive academic research at Washington University in St. Louis and MRC laboratories in the UK.

Appearances:



Day 2: 18th March 2026 @ 13:35

Panel Discussion: How can the Uptake of Approved CAR-T Therapies be Improved: Addressing Supply Costs, Access and Other Barriers?

last published: 02/Jul/25 12:55 GMT

back to speakers


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150